Imovax Polio

Dosage

Children: Refer to specific guidelines or clinical references for pediatric dosing information.

Adults: Refer to specific guidelines or clinical references for dosing information.

Pregnancy

Data on the safety of Mahoney during pregnancy is limited. It is advisable to consult a healthcare professional before use.

Breast-feeding

Safety during breastfeeding has not been established. Caution is recommended.

Storage

Store in a cool, dry place, away from direct sunlight. Keep out of reach of children.

Indications

• Prevention of poliomyelitis
• Vaccination in children and high-risk populations

Dosage

Children: Refer to the BNF for Children for appropriate dosing schedules and recommendations for poliovirus vaccination in children.

Adults: Refer to specific guidelines for IPV and OPV administration in adults, as vaccination schedules may vary based on age and immunization history.

Mechanism of action

Poliovirus primarily infects the motor neurons of the spinal cord and brainstem, leading to cell lysis and apoptosis. The viral replication occurs in the cytoplasm of the host cells, resulting in the release of new virions. The immune response triggered by the infection can lead to paralysis due to damage to the motor neurons.

Pharmacodynamics

The pharmacodynamics of polio vaccines involve the induction of an immune response against the poliovirus. The IPV induces serum neutralizing antibodies, while the OPV induces both serum and mucosal immunity. This immune response prevents the establishment of infection and protects against the disease.

Pharmacokinetics

Poliovirus vaccines do not have a pharmacokinetic profile in the traditional sense, as they are biological products. However, the IPV is administered intramuscularly, leading to systemic absorption and subsequent immunogenicity. The OPV is administered orally, leading to replication in the gastrointestinal tract and inducing both humoral and cellular immunity.

Contra-indications

• Severe allergic reaction to polio vaccine components
• Immunocompromised state (inactivated vaccine preferred)

Adverse effects

• Injection site reactions (pain, swelling, redness)
• Fever
• Fatigue
• Gastrointestinal disturbances (nausea, vomiting)
• Rarely, vaccine-derived paralytic poliomyelitis

Interactions

• Live vaccines may be affected by immunosuppressive therapies
• Concurrent administration with other vaccines is generally safe but consult vaccination guidelines

Precautions

• History of allergic reactions
• Patients with a history of Guillain-Barré syndrome
• Caution in patients with neurological disorders

Pregnancy

Polio vaccination is recommended during pregnancy if the woman is at risk of exposure, as the benefits outweigh potential risks.

Breast-feeding

Polio vaccine can be administered to breastfeeding mothers without risk to the infant.

Storage

Store at 2-8°C. Do not freeze. Protect from light.

Formulations

• Inactivated poliovirus vaccine (IPV)
• Oral poliovirus vaccine (OPV)

Indications

• Poliomyelitis prevention
• Vaccination against poliovirus
• Public health immunization programs

Dosage

Children: Refer to national immunization guidelines for childhood vaccination schedules, including IPV and OPV.

Adults: Refer to national immunization guidelines, typically involving a series of vaccinations with IPV or OPV.

Mechanism of action

Poliovirus infects host cells by binding to specific receptors on the cell surface, leading to the internalization of the virus. Once inside, poliovirus releases its RNA genome, which hijacks the host's cellular machinery to replicate and produce viral proteins. This replication can cause cell lysis and inflammation, leading to symptoms of the disease.

Pharmacodynamics

Poliovirus primarily targets motor neurons in the spinal cord and brainstem, resulting in cell death and, subsequently, muscle weakness or paralysis. The severity of the disease varies significantly, with many infections being asymptomatic, while a minority progress to paralytic disease. The immune response to the infection plays a crucial role in determining the outcome.

Pharmacokinetics

The pharmacokinetics of poliovirus is characterized by its ability to survive in the gastrointestinal tract, where it replicates before entering the bloodstream. The virus does not undergo conventional pharmacokinetic processes such as absorption, distribution, metabolism, or excretion like typical drugs, as it is a living organism. The duration of viral shedding can vary, typically lasting from a few weeks to several months, depending on the individual’s immune response.

Adverse effects

• Mild fever
• Fatigue
• Headache
• Sore throat
• Nausea
• Vomiting
• Diarrhea
• Flu-like symptoms
• Rarely, paralytic poliomyelitis

Precautions

• Monitor for signs of allergic reactions
• Patients with immunocompromised states should be assessed carefully
• Individuals should be screened for history of vaccine-associated paralytic poliomyelitis

Pregnancy

The inactivated poliovirus vaccine (IPV) is considered safe during pregnancy. Live attenuated vaccines are generally avoided.

Breast-feeding

IPV is safe for breastfeeding mothers. Live attenuated vaccines may have specific recommendations.

Storage

Store at 2 to 8 degrees Celsius. Do not freeze.

Formulations

• Inactivated poliovirus vaccine (IPV)
• Oral poliovirus vaccine (OPV)

Indications

• Fever
• Mild to moderate pain
• Headaches
• Muscle pain
• Joint pain
• Post-operative pain

Dosage

Children: Refer to BNF for Children for appropriate dosing information.

Adults: Refer to specific prescribing guidelines or BNF for exact dosing information.

Mechanism of action

The active ingredient in Saukett generally works by inhibiting cyclooxygenase (COX) enzymes, particularly COX-1 and COX-2. This inhibition decreases the synthesis of prostaglandins, which are mediators of inflammation, pain, and fever. By reducing prostaglandin levels, Saukett effectively alleviates pain and lowers body temperature in febrile conditions.

Pharmacodynamics

Saukett exhibits anti-inflammatory, analgesic, and antipyretic effects. Its analgesic action is beneficial for managing mild to moderate pain, including headaches, muscle pain, and joint pain. The antipyretic effect helps in the management of fever, providing symptomatic relief. The onset of action typically occurs within 30 to 60 minutes after oral administration, with a duration of effect that can last several hours, depending on the specific formulation used.

Pharmacokinetics

After oral administration, Saukett is absorbed from the gastrointestinal tract, with peak plasma concentrations occurring within 1 to 2 hours. It is metabolized primarily in the liver, undergoing conjugation and oxidation. The elimination half-life varies but is generally between 2 to 4 hours. The drug is excreted mainly via the kidneys, with both unchanged drug and metabolites appearing in the urine. Factors such as age, liver function, and renal function can influence the pharmacokinetics.

Indications

• Bacterial infections
• Viral infections
• Epidemiological studies
• Antibiotic resistance monitoring

Dosage

Children: Refer to specific antimicrobial treatment guidelines based on the strain identified and the infection site.

Adults: Refer to specific antimicrobial treatment guidelines based on the strain identified and the infection site.

Mechanism of action

The mechanism of action for a strain depends on the type of microorganism it represents. For pathogenic bacteria, the strain may produce toxins, evade the host's immune response, or possess resistance mechanisms that allow it to survive in the presence of antibiotics. For viruses, strains may exhibit mutations that alter their ability to infect host cells or evade antiviral therapies.

Pharmacodynamics

Pharmacodynamics in the context of strains involves the interaction between the strain and the host's immune system, as well as the effects of specific antimicrobial agents on the strain. These interactions can influence the efficacy of treatments and the development of resistance.

Pharmacokinetics

Pharmacokinetics is not directly applicable to strains themselves but rather to the drugs used to treat infections caused by specific strains. Factors such as absorption, distribution, metabolism, and excretion of antimicrobial agents can vary depending on the strain's characteristics and the site of infection.

Pregnancy

There is limited information on the safety of strain in pregnancy. It is advisable to consult healthcare professionals for guidance.

Breast-feeding

Safety during breastfeeding is not well established. It is recommended to seek medical advice before use.

Storage

Store in a cool, dry place, away from direct sunlight and moisture. Keep out of reach of children.

Indications

• Influenza
• HIV/AIDS
• Hepatitis B and C
• Herpes simplex virus infections
• Cytomegalovirus infections
• COVID-19
• Respiratory syncytial virus infections

Dosage

Children: Refer to specific antiviral agents for dosing guidance.

Adults: Refer to specific antiviral agents for dosing guidance.

Mechanism of action

Viruses infect host cells by attaching to specific receptors on the cell surface. Once inside, they hijack the host cell's machinery to replicate their genetic material and produce viral proteins. New viral particles are assembled and released from the host cell, often destroying the cell in the process. The specific mechanism can vary depending on the virus type, including integration into the host genome in retroviruses or utilizing specific pathways for replication.

Pharmacodynamics

The pharmacodynamics of antiviral agents depend on the specific virus and the mechanism of action. Antiviral drugs may inhibit viral entry into host cells, block viral replication, or prevent the assembly of new virions. The effectiveness of antiviral therapy often relates to the stage of viral replication and the immune response of the host.

Pharmacokinetics

Pharmacokinetics of antiviral drugs varies widely based on the specific medication used. Generally, antiviral agents are absorbed through the gastrointestinal tract and distributed throughout the body. They may undergo hepatic metabolism and are often excreted through the kidneys. The half-life of these drugs can range from a few hours to several days, influencing dosing schedules.